Prescription by Advertisement: Comparing U.S. and U.K. Controls on Weight-Loss Drug Marketing
By: Emmanuela Yiannikakis In the span of only a few years, GLP-1 weight-loss drugs such as Wegovy, Ozempic, and Mounjaro have become household names. Originally designed for diabetes, these drugs have redefined the global conversation around obesity treatment and, in the process, sparked an unprecedented surge in demand. According to a 2025 review, this surge […]